The incidence of liver cancer is increasing and has the potential to become a national health crisis.
While other cancer rates fall or remain static, liver cancer is on the rise. Here's why we need to start paying attention.
How to cut rates of liver cancer? Reducing hepatitis C rates would be a good start.
The newer drugs for hepatitis C might mean fewer people are diagnosed with liver cancer.
CT scan of liver cancer.
A promising new immunotherapy to treat liver cancer has been discovered.
Rates of sexually transmissible infections among the Indigenous population are still much higher than the non-Indigenous population.
The annual surveillance report of sexually transmissible infections and blood borne viruses in Australia has found notifications of sexually transmissible infections are on the rise in Australia.
Cancer patient Cao Dongxian poses with CT scan images of his intestine at a hotel room where he stays, near the Peking Union Hospital.
Developing brand new treatments and cures isn't the only way to achieve a major reduction in cancer deaths worldwide.
A woman is examined at a hepatitis ward in Uganda.
Ghana must urgently implement strategies to tackle the high burden of viral hepatitis if it's to fulfill global targets of eliminating the disease by 2030.
At over $1,300 a pill, a cure for hepatitis C comes at a high price.
Combinations of two or three hepatitis C virus direct-acting antiviral drugs taken for 8-24 weeks can cure more than 90% of people treated.
The thing all five viruses have in common is they can cause mild to very severe liver damage.
Hepatitis A, B, C, D and E are very different viruses. Hepatitis A is genetically closer to the common cold than it is to hepatitis B. Hepatitis C is closer to the virus that causes dengue fever.
Those who enter prison uninfected are at risk of becoming infected.
Worldwide, around 30 million people enter and leave prison each year. Of these people, around 4.5 million have hepatitis C, almost 1 million have HIV and 1.5 million have hepatitis B infections.
While Sydney’s medically supervised injecting centre has had positive results, we need drug consumption rooms all over the country.
With use of drugs such as ice on the rise, drug consumption rooms are now being set up in Europe to provide supervised inhalation.
150m carriers, and rising
New drug combination cures over 95% of cases but the cost would swallow the entire health budget. Pity the politicians that have to figure this one out.
The biggest growth in sexually transmitted infections is for chlamydia and gonorrhoea.
J. Michel (aka: Mitch) Carriere/Flickr
The latest instalment of Australia’s annual report card on HIV, hepatitis and sexually transmissible infections has been released this morning. Here's what experts make of the results.
The proposed Australian price for Sovaldi has not been disclosed, but in the United States a three-month course of treatment costs US$84,000.
It’s twice as common as type 1 diabetes. It kills more Australians than HIV. One in every 100 of us lives with hepatitis C, but the disease receives little attention. Worldwide, around 150 million people…
Technology has done away with the need to insert swabs into the male urethra and speculums into the vagina. Instead, blood and urine are tested.
Sexuality is a means of pleasure, fulfilment and intimate connection with other humans. But it can also be a source of anguish. So it’s perhaps no surprise that of all the areas in health care, the “STI…
Condom use appears to be declining across the Australian population.
A fall in condom use across the population is driving strong growth in sexually-transmitted infections, according to one…
Switching from intravenous to oral therapy would make it easier to access.
A new, combination hepatitis C therapy could shorten treatment times, reduce side effects and improve health outcomes for…
US researchers have determined a potential marker to identify patients prone to hepatitis C relapse after antiviral therapy…
Hepatitis B and C kill more Australians than HIV/AIDS, according to an analysis of the 2010 Global Burden of Disease study…
New treatments have minimal side effects and cure rates of over 90%.
Hepatitis C is a hidden epidemic affecting 170 million people worldwide. Hepatitis C kills nearly 700 Australians every year, mostly from chronic liver failure and liver cancer, and costs over $78.9 million…
Scientists may be a step closer to developing an effective vaccine for hepatitis C after finding the most detailed image…